Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.300
+0.040 (3.17%)
At close: May 16, 2025, 4:00 PM
1.240
-0.060 (-4.62%)
Pre-market: May 19, 2025, 5:47 AM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $3.21 million as of May 19, 2025. Its market cap has decreased by -52.62% in one year.
Market Cap
3.21M
Enterprise Value
-1.08M
1-Year Change
-52.62%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $11.31B to $3.21M, a decrease of -99.97%. That is a compound annual growth rate of -84.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 3.21M | -11.85% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.74% |
| Dec 31, 2020 | 11.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |